MENU
BIB
ETF ticker: NASDAQ
PRICE
CHANGE
NET ASSETS
ProShares Ultra Nasdaq Biotechnology (BIB) Ownership - Who owns ProShares Ultra Nasdaq Biotechnology?
Category: @Trading
Profile
Category
Trading--Leveraged Equity
Address
ProShares Trust7501 Wisconsin Avenue,Suite 1000Bethesda
Phone
N/A
Web
www.proshares.com
Details
Group
Alternative Funds
Category
Trading
Net Assets
68658960.00
Fund Existence
over 14 years
Turnover
23.00
Capitalization
N/A
Yield
0.14
Total Expense Ratio
N/A
Investment Style
N/A
Risk (Beta)
N/A
Fundamentals
BIB
Net Assets
68.7M
Yield
0.14
Fund Existence
over 14 years
Total Expense Ratio
N/A
Turnover
23.00
Investment Style
N/A
Capitalization
N/A
Risk (Beta)
N/A
Manager Tenure
N/A
Administrative Fee
N/A
Annual Report Gross Expense Ratio
N/A
Assets in Top Ten Holdings
54.7M
Average Credit Quality
N/A
Average Effective Duration
N/A
Average Effective Maturity
N/A
Fund of Funds
No
Fund Share Class Net Assets
63.2M
Fund Type
ETF
Index Fund
No
Management Fee
N/A
Modified Duration
N/A
No Load Fund
No
Number of Long Holdings
223.00
Number of Net Holdings
N/A
Number of Short Holdings
7.00
Prospectus Acquired Expense Ratio
N/A
Weighting Top Ten Holdings
N/A
Gain YTD
-1.499
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Category Trading
Profile
Fundamentals
Details
Category
Trading--Leveraged Equity
Address
ProShares Trust7501 Wisconsin Avenue,Suite 1000Bethesda
Phone
N/A
Web
www.proshares.com